Overexpression of angiotensinogen increases tubular apoptosis in diabetes

79Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The intrarenal renin-angiotensin system (RAS) plays an important role in the progression of diabetic nephropathy. We have previously reported that mice overexpressing angiotensinogen in renal proximal tubular cells (RPTC) develop hypertension, albuminuria, and renal injury. Here, we investigated whether activation of the intrarenal RAS contributes to apoptosis of RPTC in diabetes. Induction of diabetes with streptozotocin in these transgenic mice led to significant increases in BP, albuminuria, RPTC apoptosis, and proapoptotic gene expression compared with diabetic nontransgenic littermates. Insulin and/or RAS blockers markedly attenuated these changes. Hydralazine prevented hypertension but not albuminuria, RPTC apoptosis, or proapoptotic gene expression. In vitro, high-glucose medium significantly increased apoptosis and caspase-3 activity in rat immortalized RPTC overexpressing angiotensinogen compared with control cells, and these changes were prevented by insulin and/or RAS blockers. In conclusion, intrarenal RAS activation and high glucose may act in concert to increase tubular apoptosis in diabetes, independent of systemic hypertension. Copyright © 2008 by the American Society of Nephrology.

Cite

CITATION STYLE

APA

Liu, F., Brezniceanu, M. L., Wei, C. C., Chénier, I., Sachetelli, S., Zhang, S. L., … Chan, J. S. D. (2008). Overexpression of angiotensinogen increases tubular apoptosis in diabetes. Journal of the American Society of Nephrology, 19(2), 269–280. https://doi.org/10.1681/ASN.2007010074

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free